Marine Jary

8PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.

Christelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort

|Jan 31, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.

Claire Gallois, Marine Sroussi, Thierry André

|Jan 17, 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.

Christelle De La Fouchardière, David Malka, Claire Cropet

|Aug 15, 2022
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.

Thierry André, David Tougeron, Guillaume Piessen

|Dec 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.

Marine Jary, Wen-Wei Liu, Dongyao Yan

|Mar 31, 2020
Molecular description of ANGPT2 associated colorectal carcinoma.

Marine Jary, Reyhan Hasanova, Angélique Vienot

Pageof 2

Frequent Collaborators

3 joint publications

Christelle de la Fouchardière

2 joint publications

Thierry André

2 joint publications

David Tougeron

2 joint publications

Guillaume Piessen